Clinical Trial Update: Toripalimab Plus Bevacizumab Combined Three Intra-arterial Therapies (TACE, HAIC, or TACE-HAIC) for Unresectable Hepatocellular Carcinoma: a Phase 2, Multicenter Randomised Non-comparative Trial [Phase 2]

View source ↗

Summary

A Phase 2, multicenter randomized non-comparative trial is evaluating the combination of toripalimab and bevacizumab with three intra-arterial therapies for unr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Avastin (bevacizumab)
• Toripalimab (Toripalimab)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Hepatocellular Carcinoma (HCC) | Phase 2 | Status: ACTIVE_NOT_RECRUITING